MAPK pathway alterations correlate with poor survival and drive resistance to therapy in patients with lung cancers driven by ROS1 fusions
Sato, Hiroki, Schoenfeld, Adam J, Siau, Evan, Lu, Yue Christine, Tai, Huichun, Suzawa, Ken, Kubota, Daisuke, Lui, Allan JW, Qeriqi, Besnik, Mattar, Marissa, Offin, Michael, Sakaguchi, Masakiyo, ToyookJournal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.ccr-19-3321
Date:
March, 2020
File:
PDF, 18.18 MB
2020